Welcome to LookChem.com Sign In|Join Free

CAS

  • or

351002-11-4

Post Buying Request

351002-11-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

351002-11-4 Usage

General Description

Trifluoro-methanesulfonic acid 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl ester is a chemical compound with potential applications in the field of medicinal chemistry. It is a derivative of 4-oxo-4H-chromen-8-yl ester, which is known for its biological activities such as anti-inflammatory, antioxidant, and anticancer properties. The addition of a morpholin-4-yl group to the structure may enhance the compound's bioavailability and target specificity. The trifluoro-methanesulfonic acid moiety can also provide stability and solubility to the molecule, making it a promising candidate for drug development. Further research is needed to explore the full potential of this compound for therapeutic use.

Check Digit Verification of cas no

The CAS Registry Mumber 351002-11-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,0,0 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 351002-11:
(8*3)+(7*5)+(6*1)+(5*0)+(4*0)+(3*2)+(2*1)+(1*1)=74
74 % 10 = 4
So 351002-11-4 is a valid CAS Registry Number.

351002-11-4Relevant articles and documents

SYNTHESIS OF 2-AMINO-SUBSTITUTED 4-OXO-4H-CHROMEN-8.YL-TRIFLUORO-METHANESULFONIC ACID ESTERS

-

Page/Page column 33; 36, (2008/06/13)

A method of synthesising a compound of formula (I): wherein RN1 and RN2 are independently selected from hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; from a compound of formula (III): comprising the steps of: (a) removing the allyl group from the compound of formula (III) with appropriate reaction conditions to yield a compound of formula (II):; and (b) reacting the compound of formula (II) with a triflating agent to yield a compound of formula (I).

Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach

Hardcastle, Ian R.,Cockcroft, Xiaoling,Curtin, Nicola J.,El-Murr, Marine Desage,Leahy, Justin J. J.,Stockley, Martin,Golding, Bernard T.,Rigoreau, Laurent,Richardson, Caroline,Smith, Graeme C. M.,Griffin, Roger J.

, p. 7829 - 7846 (2007/10/03)

Structure-activity relationships for inhibition of DNA-dependent protein kinase (DNA-PK) have been defined for substituted chromen-4-ones. For the 2-amino-substituted benzo[h]-chromen-4-ones, a morpholine substituent at this position was essential for activity. Small libraries of 6- and 7-alkoxy-substituted chromen-4-ones showed that a number of 7-alkoxy-substituted chromenones displayed improved activity. Focused libraries incorporating 6-, 7-, and 8-aryl and heteroaryl substituents were prepared. In these cases, 6- and 7-substitution was disfavored, whereas 8-substitution was largely tolerated. Surprisingly, two compounds, 2-N-morpholino-8-dibenzofuranyl-chromen-4-one (NU7427, 32{38}) and the 2-N-morpholino-8-dibenzothiophenyl-chromen-4-one (NU7441, 32{26}) were excellent inhibitors (IC50 vs DNA-PK = 40 and 13 nM, respectively). The ring-saturated analogue 2-N-morpholino-8-(6′, 7′,8′,9′-tetrahydrodibenzothiophene)chromen-4-one, 36, retained potent activity (IC50 vs DNA-PK = 23 nM). The dibenzothiophene 32{38} sensitized HeLa cells to ionizing radiation in vitro, with dose modification factors of 2.5 at 10% survival being observed at 0.5 μM. The cytotoxicity of the topoisomerase II inhibitor etoposide was also potentiated.

Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries

Leahy, Justin J.J.,Golding, Bernard T.,Griffin, Roger J.,Hardcastle, Ian R.,Richardson, Caroline,Rigoreau, Laurent,Smith, Graeme C.M.

, p. 6083 - 6087 (2007/10/03)

A solution-phase multiple-parallel synthesis approach was employed for the preparation of 6-, 7- and 8-aryl-substituted chromenone libraries, which were screened as inhibitors of the DNA repair enzyme DNA-dependent protein kinase (DNA-PK). These studies r

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 351002-11-4